Skip to main content

Table 3 Effect of flaxseed oil supplementation on AEA status

From: Effect of flaxseed oil supplementation on the erythrocyte membrane fatty acid composition and endocannabinoid system modulation in patients with coronary artery disease: a double-blind randomized controlled trial

Variable

Flaxseed oil (n = 21)

Placebo (n = 19)

MD (95% CI), P value

AEA (ng/ml)

 Before

5.45 (2.98)

6.76 (2.72)

1.31 (− 0.54 to 3.17), 0.158a

 After

4.73 (2.67)

6.44 (2.44)

0.64 (0.12 to 1.15), 0.016b

MD (95% CI), P valuec

− 0.71 (− 1.08 to − 0.34), 0.001

− 0.32 (− 0.70 to 0.05), 0.091

 
  1. Values are expressed as mean (SD)
  2. AEA N-arachidonoyl ethanolamine, MD mean difference
  3. aIndependent samples t-test
  4. bAdjusted for baseline values, weight differences, energy intake changes and fat intake changes using the analysis of covariance (ANCOVA) test
  5. cPaired-samples t-test